-

Federal Judge Remands Monsanto Class Settlement Case Back to MO State Court

LEVERKUSEN, Germany & ST. LOUIS--(BUSINESS WIRE)--Today, Judge Henry E. Autrey, a federal district court judge in the Eastern District of Missouri, today issued a ruling remanding the class settlement case, King v Monsanto, back to Missouri State Court. Monsanto released the following statement in response to the Court’s decision.

“This decision returns jurisdiction over the class settlement to Missouri Circuit Court where the vast majority of pending claims in the Roundup litigation have been filed. This decision brings much needed clarity to all parties and will enable the class approval process to continue to move forward. It also renders the related JPML proceedings moot, as this Court has determined the case belongs in state, rather than federal court.

“Monsanto remains confident that the class settlement, which is supported by plaintiffs’ counsel representing tens of thousands of potential class members, is fair to all parties and the objections have no merit.”

Contacts

Media Contact:
Brian Leake (314) 370-3285

Bayer


Release Versions

Contacts

Media Contact:
Brian Leake (314) 370-3285

More News From Bayer

Bayer and Henry Ford Health Announce Strategic Research Partnership to Expand Patient Access to Clinical Trials

DETROIT--(BUSINESS WIRE)--Bayer, a global life sciences company, and Henry Ford Health today announced a strategic partnership to expand clinical trial opportunities for patients. The work brings together Bayer’s global drug development expertise with Henry Ford Health’s comprehensive clinical research program and its deep connection to the communities it serves. “Clinical trials are often the first opportunity patients have to access cutting-edge treatments,” said Dr. David Lanfear, Chief Scie...

The University of Colorado Anschutz, along with UCHealth and Children’s Hospital Colorado, Form Strategic Alliance with Bayer to Advance Drug Development and Clinical Trials

AURORA, Colo. & WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer, a global life sciences company, has announced a new strategic alliance focused on clinical trials collaboration with the University of Colorado Anschutz, UCHealth and Children’s Hospital Colorado, establishing Bayer’s first alliance of its kind with an academic medical center. The initiative reflects a shared commitment to accelerating clinical research through stronger collaboration between industry and academic medicine. The alliance is...
Back to Newsroom